Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 20956 AL 20970

Role of mtDNA disturbances in the pathogenesis of Alzheimer's and Parkinson's disease

Antonyová V, Kejík Z, Brogyányi T, Kaplánek R, Pajková M, Talianová V, Hromádka R, Masařík M, Sýkora D, Mikšátková L, Martásek P, Jakubek M.

DNA Repair (Amst). 2020 Jul-Aug;91-92:102871. doi: 10.1016/j.dnarep.2020.102871. Epub 2020 May 21.

Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease

Irwin DJ, Fedler J, Coffey CS, Caspell-Garcia C, Kang JH, Simuni T, Foroud T, Toga AW, Tanner CM, Kieburtz K, Chahine LM, Reimer A, Hutten S, Weintraub D, Mollenhauer B, Galasko DR, Siderowf A, Marek K, Trojanowski JQ, Shaw LM; Parkinson's Progression Marker Initiative.

Ann Neurol. 2020 Sep;88(3):574-587. doi: 10.1002/ana.25811. Epub 2020 Jul 2.

Potential for Treatment of Neurodegenerative Diseases with Natural Products or Synthetic Compounds that Stabilize Microtubules

Miller JH, Das V.

Curr Pharm Des. 2020;26(35):4362-4372. doi: 10.2174/1381612826666200621171302.

Progress toward Alzheimer's disease treatment: Leveraging the Achilles' heel of Aβ oligomers?

Fantini J, Chahinian H, Yahi N.

Protein Sci. 2020 Aug;29(8):1748-1759. doi: 10.1002/pro.3906. Epub 2020 Jul 13.

Multi-angle development of therapeutic methods for Alzheimer's disease

Hoshi M.

Br J Pharmacol. 2021 Feb;178(4):770-783. doi: 10.1111/bph.15174. Epub 2020 Jul 16.

Rapid improvement in Alzheimer's disease symptoms following fecal microbiota transplantation: a case report

Hazan S.

J Int Med Res. 2020 Jun;48(6):300060520925930. doi: 10.1177/0300060520925930.

A Comparison of Serial Position Effects in Patients with Mild Cognitive Impairment due to Parkinson's Disease or to Alzheimer's Disease

Meyer A, Handabaka I, Ehrensperger MM, Gschwandtner U, Hatz F, Monsch AU, Stieglitz RD, Fuhr P.

Dement Geriatr Cogn Disord. 2020;49(2):170-178. doi: 10.1159/000507757. Epub 2020 Jul 7.

Epigenetic Basis of Lead-Induced Neurological Disorders

Wang T, Zhang J, Xu Y.

Int J Environ Res Public Health. 2020 Jul 7;17(13):4878. doi: 10.3390/ijerph17134878.

Glibenclamide as a neuroprotective antidementia drug

Zubov A, Muruzheva Z, Tikhomirova M, Karpenko M.

Arch Physiol Biochem. 2022 Dec;128(6):1693-1696. doi: 10.1080/13813455.2020.1789170. Epub 2020 Jul 11.

Endosomal Trafficking in Alzheimer's Disease, Parkinson's Disease, and Neuronal Ceroid Lipofuscinosis

Qureshi YH, Baez P, Reitz C.

Mol Cell Biol. 2020 Sep 14;40(19):e00262-20. doi: 10.1128/MCB.00262-20. Print 2020 Sep 14.

New antipsychotic drugs for the treatment of agitation and psychosis in Alzheimer's disease: focus on brexpiprazole and pimavanserin

Caraci F, Santagati M, Caruso G, Cannavò D, Leggio GM, Salomone S, Drago F.

F1000Res. 2020 Jul 8;9:F1000 Faculty Rev-686. doi: 10.12688/f1000research.22662.1. eCollection 2020.

The Functional Roles and Applications of Immunoglobulins in Neurodegenerative Disease

Sim KY, Im KC, Park SG.

Int J Mol Sci. 2020 Jul 26;21(15):5295. doi: 10.3390/ijms21155295.

Endosomal-lysosomal dysfunction in metabolic diseases and Alzheimer's disease

Almeida MF, Bahr BA, Kinsey ST.

Int Rev Neurobiol. 2020;154:303-324. doi: 10.1016/bs.irn.2020.02.012. Epub 2020 Jul 10.

The NLRP3 inflammasome as a bridge between neuro-inflammation in metabolic and neurodegenerative diseases

Söderbom G, Zeng BY.

Int Rev Neurobiol. 2020;154:345-391. doi: 10.1016/bs.irn.2020.03.023. Epub 2020 Jul 17.

[Mitochondrial genome variants and neurodegenerative diseases]

Ni J, Wang J.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2020 Aug 10;37(8):898-902. doi: 10.3760/cma.j.issn.1003-9406.2020.08.023.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias